Please Wait
Applying Filters...
menu
    • menu
    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Lupin Manufacturing Solutions – delivering high-quality APIs & end-to-end CDMO services for faster, cost-effective drug development.

    Virtual Booth

    Contact Supplier

    Minakem delivers API, HPAPI, steroids & CDMO services for generics with FDA/GMP certification, regulatory know-how & proven success.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    An Enquiry

    Menu

    Pfizer Inc

    EVENTS

    • Webinars & Exhibitions

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    EXCIPIENTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital content

    Create Content with PharmaCompass, ask us

    INTERVIEW #SpeakPharma

    [Sponsored by another company]
    “We’re investing in next-gen CDMO & peptide building blocks infrastructure to support the evolving demands of complex therapies.”

    mic“We’re investing in next-gen CDMO & peptide building blocks infrastructure to support the evolving demands of complex therapies.”

    This week, SpeakPharma interviews Dr. Abdelaziz Toumi, Chief Executive Officer of Lupin Manufacturing Solutions (LMS). In this exclusive interview with PharmaCompass, Dr. Toumi discusses the evolving CDMO landscape, the shift toward complex therapies and growing peptide ecosystems along with LMS’s recent strategic investments in integrated CDMO and peptide building blocks infrastructure. As the industry convenes at DCAT Week, he highlights how LMS is positioning itself as a capability-driven CDMO partner for next-gen complex therapies.Dr. Toumi, The US has been taking several steps to reduce dependence on overseas pharmaceutical supply chains. How is Lupin Manufacturing Solutions (LMS) navigating these shifts?The framing of this debate as globalization versus reshoring misses what is actually happening. What we are seeing is a deliberate recalibration, a move from networks built purely for cost efficiency toward architectures that distribute risk more intelligently. That is a fundamentally different objective, and it changes what pharmaceutical companies expect from their manufacturing partners. What policymakers are pushing for, whether through the BIOSECURE Act or broader reshoring incentives, is a strategic allocation of manufacturing risk, and that is entirely rational.For LMS, this environment plays to our strengths. We have never positioned ourselves as a low-cost volume provider. Our competitive case is built on technical capability, regulatory reliability, and the ability to manage genuinely complex chemistry programs. Those attributes matter most to customers re-evaluating their supply relationships. Our investments in HPAPI containment, peptide building blocks, and integrated CDMO infrastructure reflect a deliberate commitment to being relevant precisely where complexity is highest. That is where we see sustained and growing demand, irrespective of how supply chain policy continues to evolve.How do you see the pharmaceutical landscape evolving over the next five years? How is LMS positioning itself to stay ahead of these changes?Five years from now, the defining feature of this industry will be the sheer scientific complexity embedded in pharmaceutical pipelines. Peptides, targeted oncology compounds, radiopharmaceuticals, these are not molecules you manufacture through conventional means. They demand deep process chemistry, specialized infrastructure, and partners who can genuinely co-develop solutions rather than simply execute a manufacturing order.That shift is changing how innovation-driven companies select their CDMO partners. Technical depth, regulatory track record, and the ability to navigate development risk have moved to the top of the evaluation criteria. At LMS, everything we are building right from our integrated CDMO block at Dabhasa to our HPAPI infrastructure at Vizag is calibrated to this reality. We are positioning to be a partner of choice and not just a transactional service provider.Could you provide an update on LMS’ oncology (HPAPI) manufacturing block in Visakhapatnam? How is it contributing to your CDMO strategy?Oncology manufacturing is one of the most technically exciting segments in the industry, and that complexity is only intensifying. As targeted therapies and antibody drug conjugates advance through pipelines, the demand for high-potency API capability delivered reliably, at global safety standards continues to grow.Our Vizag facility has been designed with that reality in mind, and that goes beyond containment engineering. It incorporates the process discipline, safety culture, and quality systems that high-potency manufacturing demands at every level of the organization. You cannot retrofit this kind of capability; it has to be purpose-built. What we have put in place is a platform that supports programs from early clinical development through commercial supply offering customers the continuity they need without transferring between sites as their programs mature. That continuity is a genuine competitive advantage.In December, LMS signed a strategic alliance with PolyPeptide Group AG to scale the global peptide supply chain. How will this collaboration strengthen your CDMO capabilities in the fast-growing peptide therapeutics segment?The rapid growth of peptide therapeutics, especially GLP1s, has fundamentally changed how the industry thinks about scale, reliability, and supply security. What was once a niche capability has become a core requirement, and customers are now looking for partners who can support the peptide value chain end-to-end, at a global scale.LMS’s strategy is built around serving the entire peptide market and establishing a globally competitive platform over the next three to five years, rooted in India, positioning itself as a credible partner amidst the China+1 strategy, capable of supporting both innovators and large pharmaceutical companies. The strategic alliance with PolyPeptide Group fits naturally within this vision allowing us to complement our own capabilities with additional synthesis depth and geographic flexibility, particularly for customers seeking resilient, diversified supply chains.LMS brings deep process chemistry expertise, a growing peptide intermediates and building blocks platform at Dabhasa, and strong regulatory execution. Importantly, as part of the Lupin group, we are also able to offer downstream drug product manufacturing capabilities spanning oral formulations as well as sterile injectables, including vials and drug-device delivery systems, which are increasingly critical as peptide programs move rapidly from development to commercial scale.Together, this integrated approach allows us to support customers across the full lifecycle, from peptide intermediates and APIs through to finished dosage forms. In a market defined by speed, scale, and supply assurance, this breadth of capability positions LMS to emerge as one of the leading global players in peptide CDMO services.As the industry convenes at DCAT Week, what is LMS bringing to the table this year?This year is about laying the foundations for LMS’s next phase of growth, particularly in complex and high value modalities. Strategically, our focus is on building the capabilities required to support emerging oncology and peptide adjacent platforms, while preparing for commercial scale-up over the next 18-24 months.On the technology side, LMS already has strong R&D capabilities across peptides, payloads and linkers, bioconjugation, and high potent compounds. These capabilities allow us to engage with customers early in development, solve complex chemistry challenges, and support rapid transition from discovery into development programs. Building on this base, we are progressing plans to establish commercial-scale GMP capacities in payload-linker synthesis and bioconjugation, including the development of a dedicated GMP facility in Vizag. This is a critical step for us as more antibody drug conjugates and related platforms move toward late-stage development and commercialization.Equally important is how we engage with customers. Alongside traditional CDMO models, we are increasingly offering alternative business models such as dedicated facilities, long-term capacity commitments, and guaranteed supply arrangements designed to address customers’ growing concerns around security, scalability, and speed to market. Overall, the year ahead is about execution including strengthening our R&D engine, advancing commercial-scale infrastructure, and deepening customer partnerships so that LMS is well positioned to support complex programs as they move into clinical and commercial reality.LMS has articulated its ambition to emerge as a trusted global CDMO partner with next-generation manufacturing capabilities and scientific agility. How would you assess your progress toward that goal?Trusted partnerships are earned over time, and I am clear-eyed about that. What I can say with confidence is that the strategic choices we have made over the past year have been the right ones, and the investment portfolio we have assembled aligns with direction the industry is heading.The development of our integrated CDMO block at Dabhasa, the scaling of peptide building blocks capabilities, the Vizag HPAPI facility, the PolyPeptide alliance, these reflect a coherent long-term strategy. What continues to occupy my attention most is execution. Infrastructure sets the stage, but it is our science, our quality systems, and our people that customers will ultimately judge us by. That work is ongoing, and it is where I spend most of my time.Could you update us on LMS’ green manufacturing initiatives? How is sustainability being integrated into your operations and facilities?Sustainability has shifted from a compliance requirement to a genuine competitive dimension, and I think that shift is permanent. Customers, investors, and regulators are asking harder questions, and organizations treating it just as a reporting exercise will find themselves at a disadvantage.Our approach remains grounded in the belief that durable environmental improvement comes from process intelligence. When you optimize synthesis routes for atom economy, reduce solvent intensity, and engineer waste out at the design stage, you improve sustainability and manufacturing economics simultaneously. These are not competing priorities. We are embedding green chemistry principles across our development workflows and investing in solvent recovery and waste management infrastructure. Our parent organization Lupin Limited was recently recognized among the top 1% of companies worldwide in the S&P Global Corporate Sustainability Assessment (CSA) attaining an overall score of 91 out of 100 establishing itself as the leading pharmaceutical company globally, and the leader across all sectors in India, surpassing both Indian and international peers which underscores our commitment.

    Impressions: 1402

    subscribeSubscribe

    https://www.pharmacompass.com/speak-pharma/we-re-investing-in-next-gen-cdmo-peptide-building-blocks-infrastructure-to-support-the-evolving-demands-of-complex-therapies

    PharmaCompass
    24 Mar 2026
    Share info Share

    VLOG #PharmaReel

    [Sponsored by another company]

    ReelPharmaGlobal Leader in HPLE ExcipientsGlobal Leader in HPLE Excipients

    Global Leader in HPLE Excipients
    Global Leader in HPLE Excipients

    reelGlobal Leader in HPLE Excipients

    This PharmaReel highlights Pfanstiehl, a global leader in high-purity, low-endotoxin, low-metal injectable-grade excipients for biologic formulations under cGMP standards, with expertise in isolation, purification, custom synthesis, and scale-up from gram-scale to multi-ton production.

    Impressions: 6

    read-more

    DATA COMPILATION #PharmaFlow

    [Sponsored by another company]
    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

    The market for pharmaceutical excipients — or inactive substances used in the production of drugs —  continued to witness significant transformation in the first quarter (Q1) of 2026. The rise of biologics, increasing demand for personalized medicine, and innovations in drug delivery systems are driving demand for a wider range of functional excipients. As a result, the pharmaceutical excipients market is estimated to grow at a compound annual growth rate (CAGR) of 5.75 percent, to exceed US$ 15.43 billion by 2034. Its size was estimated at US$ 9.31 billion in 2025. The North American market for excipients was estimated at US$ 3.1 billion in 2024 and is estimated to increase to US$ 5.66 billion by 2034. In comparison, the European market for pharmaceutical excipients was estimated at US$ 2.35 billion in 2024 and is predicted to reach around US$ 3.95 billion by 2034, while the Asia Pacific market stood at US$ 1.94 billion in 2024 and is projected to grow to US$ 3.65 billion by 2034.The sector remains highly competitive and fragmented. Major excipient providers include BASF, Roquette, Gangwal Healthcare, Croda International, DuPont, Seqens, SPI Pharma, Evonik, PMC Isochem, Pfanstiehl, Colorcon, Kewpie Corporation, ICE Pharma, Nanjing Well Pharmaceutical, Merck KGaA-owned MilliporeSigma, Minakem, Ashland Global and Nippon Fine Chemical.Clariant sets up its first PEG excipients facility in US; Croda opens greenfield facility in India Swiss specialty chemical company Clariant is expanding its Clear Lake (Texas) site to include GMP-compliant manufacturing of pharmaceutical-grade polyethylene glycol (PEG) excipients. This will improve availability and reliability for North American customers, with extended reach to Latin America. The multi-phase expansion addresses critical industry priorities around supply chain security, continuity, and responsiveness while demonstrating Clariant’s long-term strategic commitment to the US pharmaceutical market. This is the first Clariant facility in the US to manufacture PEG excipients for oral and topical applications.British specialty chemicals company Croda International has inaugurated a greenfield manufacturing facility in Dahej, India, that strengthens its ability to serve fast-growing markets in Asia. The new site represents a significant investment in India and will enhance Croda’s supply capabilities, improve responsiveness to customer demand, and support future growth in high-value sectors. Located in Gujarat, the facility benefits from strong logistics connectivity and is designed to serve both domestic customers and select export markets. It will support demand across Croda’s consumer care, life sciences, and industrial specialties sectors. Following the acquisition of IFF Pharma Solutions in 2025, French excipient company Roquette has introduced an expanded cosmetics portfolio under the Roquette Beauté brand. This portfolio integrates IFF Pharma Solutions’ ingredients — Methocel, Avicel, Aquacoat, Ethocel, and Polyox — with Roquette’s legacy range, while its core portfolio continues to include widely used pharmaceutical excipients. View Our Dashboard on Major Excipient Companies in 2026 (Free Excel Available)SPI Pharma-Anek Prayog, Ingredion-Univar ink distribution deals; DFE Pharma, Gericke launch CM platformIn February, US-based pharmaceutical excipient and ingredients company SPI Pharma announced a global distribution partnership with Indian pharmaceutical excipient manufacturer Anek Prayog. Under this agreement, SPI will exclusively sell, promote, and distribute Lubripharm Pro SSF, a next-generation sodium stearyl fumarate lubricant manufactured by Anek Prayog.The Ingredients + Specialties division of Univar Solutions was appointed as a distributor for Ingredion Pharma Solutions. The agreement includes distribution of Ingredion’s global pharmaceuticals portfolio and positions Univar as the exclusive distributor of pharmaceutical starches in the US and Canada. The partnership expands its pharmaceutical and nutraceutical excipient offerings, including binders, fillers, superdisintegrants, lubricants, and gelatin alternatives.German excipient solutions company DFE Pharma has launched a continuous manufacturing (CM) platform in collaboration with Switzerland-based Gericke Group to support formulation development, optimization, and lifecycle management. The platform integrates CM-ready excipients, a flexible evaluation environment, and multidisciplinary expertise to enable data-driven decisions from early development to commercial manufacturing.As part of this initiative, DFE Pharma has established CM capabilities at its C2F Center of Excellence in Hyderabad, featuring a Gericke Formulation Skid (GFS) in a non-GMP setup. This modular system enables rapid testing, process optimization, and practical assessment of continuous feeding and blending without impacting existing GMP operations, while supporting alignment with ICH Q13 (an international guideline on CM for drug substances and products).Gangwal Healthcare operates EXCiPACT-certified GMP facilities and offers a broad range of functional excipients, including co-processed blends like ProBlend, Starlose, Tyloxapole, and Microlose. Its excipients, including Solvostar (sodium starch glycolate) and LubMag-W (Magnesium Stearate, Sodium Lauryl Sulfate), support enhanced tablet disintegration and drug release. The company also provides taste-masking agents such as SucreX (sucralose) and CutCal (neotame), supporting the development of patient-friendly oral dosage forms. View Our Dashboard on Major Excipient Companies in 2026 (Free Excel Available)India harmonizes 22 excipient monographs; EMA updates TE guidelines for inhalation products Regulators are increasingly tightening requirements around excipients, as they are no longer treated as passive ingredients. They are being recognized as critical to product performance and therapeutic equivalence.India has introduced the Indian Pharmacopoeia 2026 with updated and harmonized standards for pharmaceutical ingredients, including 22 excipient monographs. These revisions align Indian standards more closely with global pharmacopoeias. For excipient manufacturers and drug formulators, this means stricter compliance expectations. In August, India had notified an amendment to the Drugs Rules, 1945 to mandate inclusion of qualitative details of excipients in drug labels through barcodes or QR codes from 2026.The European Medicines Agency (EMA) has issued updated guidelines on the pharmaceutical quality of inhalation and nasal medicines, as well as on demonstrating therapeutic equivalence (TE) of orally inhaled products (OIP) for asthma and chronic obstructive pulmonary disease. These guidelines require manufacturers to provide detailed information on the active substance, finished product composition, pharmaceutical development studies, and the control of excipients and other formulation components. Similar pharmaceutical quality requirements apply to nasal products under the pharmaceutical quality guideline.Excipients are becoming increasingly linked to manufacturing technologies. For instance, the US Food and Drug Administration (FDA) finalized its Advanced Manufacturing Technologies (AMT) Designation Program in 2024. This is expected to increase the need for excipients compatible with such technologies. View Our Dashboard on Major Excipient Companies in 2026 (Free Excel Available)Our view While the market for excipients is growing at a healthy pace, the ongoing conflict in the Middle East is disrupting pharmaceutical supply chains, with impacts now extending beyond APIs to critical excipients and packaging materials. Surging crude oil prices are driving up the cost of excipients, with key inputs like chloroform witnessing sharp price increases. In addition, disruptions in logistics are forcing drugmakers to reroute shipments through longer and more expensive routes due to closure of airports and certain sea routes. These developments will have a cascading effect on the pharmaceutical industry and its supply chain in the coming months.
    subscribeSubscribe
    ExcelExcel Download

    Impressions: 1071

    https://www.pharmacompass.com/radio-compass-blog/excipient-market-overview-clariant-sets-up-its-first-peg-excipients-facility-in-us-india-harmonizes-22-excipient-monographs

    #PharmaFlow by PHARMACOMPASS
    26 Mar 2026
    Share Share

    NEWS #PharmaBuzz

    [Sponsored by another company]read-more
    read-more
    Poland, Romania Ordered To Pay $2.2B In Pfizer COVID Vax Suit
    Poland, Romania Ordered To Pay $2.2B In Pfizer COVID Vax Suit

    02 Apr 2026

    // FIERCE PHARMA

    https://www.fiercepharma.com/pharma/poland-romania-must-pay-pfizer-22b-missed-covid-vaccine-deliveries-belgain-court-rules

    FIERCE PHARMA
    02 Apr 2026
    Share Share
    Pfizer, BioNTech Halt US COVID Vaccine Trial Over Safety Issues
    Pfizer, BioNTech Halt US COVID Vaccine Trial Over Safety Issues

    02 Apr 2026

    // BIOSPACE

    https://www.biospace.com/drug-development/pfizer-biontech-halt-large-us-covid-19-vaccine-trial-over-slow-enrollment

    BIOSPACE
    02 Apr 2026
    Share Share
    Pfizer, BioNTech halt COVID vaccine study after struggles
    Pfizer, BioNTech halt COVID vaccine study after struggles

    01 Apr 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-biontech-halt-us-covid-vaccine-study-after-recruitment-struggles-2026-04-01/

    REUTERS
    01 Apr 2026
    Share Share
    Why Valneva CEO Remains Bullish On Pfizer-Partnered Lyme Vaccine
    Why Valneva CEO Remains Bullish On Pfizer-Partnered Lyme Vaccine

    01 Apr 2026

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/valneva-ceo-pfizer-partnered-lyme-vaccine-why-phase-3-miss-doesnt-tell-whole-story

    FIERCE BIOTECH
    01 Apr 2026
    Share Share
    Pfizer Schedules May 5 Analyst Conference Call Webcast
    Pfizer Schedules May 5 Analyst Conference Call Webcast

    24 Mar 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260324798540/en/Pfizer-Invites-Public-to-View-and-Listen-to-Webcast-of-May-5-Conference-Call-with-Analysts

    BUSINESSWIRE
    24 Mar 2026
    Share Share
    Pfizer-Valneva Lyme disease shot shows more than 70% efficacy
    Pfizer-Valneva Lyme disease shot shows more than 70% efficacy

    23 Mar 2026

    // REUTERS

    https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-valneva-lyme-disease-shot-shows-more-than-70-efficacy-late-stage-trial-2026-03-23/

    REUTERS
    23 Mar 2026
    Share Share
    Contact Pfizer Inc and get a quotation

    Pfizer Inc is a supplier offers 272 products (APIs, Excipients or Intermediates).

    Find a price of Betamethyl Epoxide bulk with DMF, JDMF offered by Pfizer Inc

    Find a price of Epoprostenol Sodium bulk with DMF, JDMF offered by Pfizer Inc

    Find a price of Methylprednisolone bulk with DMF, CEP offered by Pfizer Inc

    Find a price of Prednisolone bulk with JDMF offered by Pfizer Inc

    Find a price of Dexamethasone bulk with JDMF offered by Pfizer Inc

    Find a price of Estradiol Cypionate bulk with DMF offered by Pfizer Inc

    Find a price of Estramustine Sodium Phosphate bulk with DMF offered by Pfizer Inc

    Find a price of Methylprednisolone Acetate bulk with DMF offered by Pfizer Inc

    Find a price of Alprazolam bulk with CEP offered by Pfizer Inc

    Find a price of Betamethasone bulk offered by Pfizer Inc

    Find a price of Betamethasone Valerate bulk offered by Pfizer Inc

    Find a price of Cabergoline bulk offered by Pfizer Inc

    Find a price of Calicheamicin bulk with DMF offered by Pfizer Inc

    Find a price of CAS 50-28-2 bulk offered by Pfizer Inc

    Find a price of Chlormadinone Acetate bulk with JDMF offered by Pfizer Inc

    Find a price of Clindamycin Palmitate bulk with DMF offered by Pfizer Inc

    Find a price of Clindamycin Phosphate bulk with DMF offered by Pfizer Inc

    Find a price of Cortisone bulk offered by Pfizer Inc

    Find a price of Diflorasone bulk offered by Pfizer Inc

    Find a price of Dinoprostone bulk with DMF offered by Pfizer Inc

    Find a price of Doxorubicin Hydrochloride bulk with DMF offered by Pfizer Inc

    Find a price of Flumethasone bulk offered by Pfizer Inc

    Find a price of Fluoxymesterone bulk offered by Pfizer Inc

    Find a price of Glipizide bulk with DMF offered by Pfizer Inc

    Find a price of Hydrocortisone Sodium Succinate bulk with CEP offered by Pfizer Inc

    Find a price of Lincomycin Hydrochloride bulk with DMF offered by Pfizer Inc

    Find a price of Megestrol Acetate bulk with DMF offered by Pfizer Inc

    Find a price of Methylprednisolone bulk offered by Pfizer Inc

    Find a price of Methylprednisolone Hemisuccinate bulk with CEP offered by Pfizer Inc

    Find a price of Piroxicam bulk with CEP offered by Pfizer Inc

    Find a price of Prednisolone Acetate bulk offered by Pfizer Inc

    Find a price of Progesterone bulk with JDMF offered by Pfizer Inc

    Find a price of Triamcinolone bulk offered by Pfizer Inc

    Find a price of Triamcinolone Acetonide bulk offered by Pfizer Inc

    Find a price of Triamcinolone Diacetate bulk offered by Pfizer Inc

    Find a price of 9-Aminocamptothecin bulk offered by Pfizer Inc

    Find a price of Acecainide bulk offered by Pfizer Inc

    Find a price of Acivicin bulk offered by Pfizer Inc

    Find a price of Amphotericin B bulk offered by Pfizer Inc

    Find a price of Ampicillin Sodium bulk offered by Pfizer Inc

    Find a price of Ampicillin Trihydrate bulk offered by Pfizer Inc

    Find a price of Arginine Vasopressin bulk offered by Pfizer Inc

    Find a price of Arlitene bulk offered by Pfizer Inc

    Find a price of Aspirin bulk offered by Pfizer Inc

    Find a price of Atorvastatin bulk offered by Pfizer Inc

    Find a price of Bacampicillin bulk offered by Pfizer Inc

    Find a price of Bacitracin Zinc bulk offered by Pfizer Inc

    Find a price of Benzylpenicillin Sodium bulk offered by Pfizer Inc

    Find a price of Betamethasone Benzoate bulk offered by Pfizer Inc

    Find a price of Betamethasone Dipropionate bulk offered by Pfizer Inc

    Find a price of Carbenicillin Indanyl bulk offered by Pfizer Inc

    Find a price of Carboxylic Acid bulk offered by Pfizer Inc

    Find a price of CAS 71-58-9 bulk offered by Pfizer Inc

    Find a price of Cefixime bulk offered by Pfizer Inc

    Find a price of Cefoperazone Sodium bulk offered by Pfizer Inc

    Find a price of Chloramphenicol Palmitate bulk offered by Pfizer Inc

    Find a price of Chloramphenicol Succinate Acid bulk offered by Pfizer Inc

    Find a price of Chlorhexidine Gluconate bulk offered by Pfizer Inc

    Find a price of Chlorpropamide bulk offered by Pfizer Inc

    Find a price of Chlortetracycline Hydrochloride bulk offered by Pfizer Inc

    Find a price of Chondroitin Sulfate Sodium bulk offered by Pfizer Inc

    Find a price of Clindamycin Hydrochloride bulk offered by Pfizer Inc

    Find a price of Clindamycin Phosphate bulk offered by Pfizer Inc

    Find a price of Cycloheximide bulk offered by Pfizer Inc

    Find a price of Cytarabine bulk offered by Pfizer Inc

    Find a price of Dacarbazine bulk offered by Pfizer Inc

    Find a price of Deferoxamine Mesylate bulk offered by Pfizer Inc

    Find a price of Demeclocycline Hydrochloride bulk offered by Pfizer Inc

    Find a price of Diphenhydramine bulk offered by Pfizer Inc

    Find a price of Doxorubicin Hydrochloride bulk offered by Pfizer Inc

    Find a price of Doxycycline Hyclate bulk offered by Pfizer Inc

    Find a price of Edoxudin bulk offered by Pfizer Inc

    Find a price of Erythromycin bulk offered by Pfizer Inc

    Find a price of Erythromycin Stearate bulk offered by Pfizer Inc

    Find a price of Estradiol bulk offered by Pfizer Inc

    Find a price of Estramustine Sodium Phosphate bulk offered by Pfizer Inc

    Find a price of Ethinyl Estradiol bulk offered by Pfizer Inc

    Find a price of Etodolac bulk offered by Pfizer Inc

    Find a price of Exemestane bulk offered by Pfizer Inc

    Find a price of Fedotozine Tartrate bulk offered by Pfizer Inc

    Find a price of Fludrocortisone Acetate bulk offered by Pfizer Inc

    Find a price of Fluocinolone Acetonide bulk offered by Pfizer Inc

    Find a price of Fluorometholone bulk offered by Pfizer Inc

    Find a price of Hydrocortisone bulk offered by Pfizer Inc

    Find a price of Hydrocortisone Sodium Succinate bulk offered by Pfizer Inc

    Find a price of Hydrogen Peroxide bulk offered by Pfizer Inc

    Find a price of Hydroxyprogesterone Caproate bulk offered by Pfizer Inc

    Find a price of Ibuprofen bulk offered by Pfizer Inc

    Find a price of Idarubicin Hydrochloride bulk offered by Pfizer Inc

    Find a price of Lysergic Acid bulk offered by Pfizer Inc

    Find a price of Lysine Hydrochloride bulk offered by Pfizer Inc

    Find a price of Meclofenamic Acid bulk offered by Pfizer Inc

    Find a price of Medroxyprogesterone Acetate bulk offered by Pfizer Inc

    Find a price of Medrysone bulk offered by Pfizer Inc

    Find a price of Menogarol bulk offered by Pfizer Inc

    Find a price of Metergoline bulk offered by Pfizer Inc

    Find a price of Methacycline Hydrochloride bulk offered by Pfizer Inc

    Find a price of Methaqualone bulk offered by Pfizer Inc

    Find a price of Methotrexate bulk offered by Pfizer Inc

    Find a price of Methyl Testosterone bulk offered by Pfizer Inc

    Find a price of Methylprednisolone Hemisuccinate bulk offered by Pfizer Inc

    Find a price of Minocycline Hydrochloride bulk offered by Pfizer Inc

    Find a price of Minoxidil bulk offered by Pfizer Inc

    Find a price of Mithramycin bulk offered by Pfizer Inc

    Find a price of Neomycin Sulfate bulk offered by Pfizer Inc

    Find a price of Nicotine bulk offered by Pfizer Inc

    Find a price of Nystatin bulk offered by Pfizer Inc

    Find a price of Olsalazine bulk offered by Pfizer Inc

    Find a price of Oxytetracycline Calcium bulk offered by Pfizer Inc

    Find a price of Oxytetracycline Dihydrate bulk offered by Pfizer Inc

    Find a price of Oxytetracycline Hydrochloride bulk offered by Pfizer Inc

    Find a price of Penicillin G Benzathine bulk offered by Pfizer Inc

    Find a price of Penicillin G Procaine bulk offered by Pfizer Inc

    Find a price of Penicillin V Potassium bulk offered by Pfizer Inc

    Find a price of Pentostatin bulk offered by Pfizer Inc

    Find a price of Phenytoin Sodium bulk offered by Pfizer Inc

    Find a price of Piperacillin Sodium bulk offered by Pfizer Inc

    Find a price of Polyethylene Glycol Monostearate bulk offered by Pfizer Inc

    Find a price of Prednisolone bulk offered by Pfizer Inc

    Find a price of Prednisolone Sodium Phosphate bulk offered by Pfizer Inc

    Find a price of Prednisone bulk offered by Pfizer Inc

    Find a price of Prednisone Acetate bulk offered by Pfizer Inc

    Find a price of Reserpine bulk offered by Pfizer Inc

    Find a price of Rifabutin bulk offered by Pfizer Inc

    Find a price of Silicon Dioxide API bulk offered by Pfizer Inc

    Find a price of Spectinomycin HCl bulk offered by Pfizer Inc

    Find a price of Streptomycin bulk offered by Pfizer Inc

    Find a price of Testolactone bulk offered by Pfizer Inc

    Find a price of Testosterone Enanthate bulk offered by Pfizer Inc

    Find a price of Tetracycline bulk offered by Pfizer Inc

    Find a price of Tetracycline Hydrochloride bulk offered by Pfizer Inc

    Find a price of Tinidazole bulk offered by Pfizer Inc

    Find a price of Tirilazad bulk offered by Pfizer Inc

    Find a price of Tolbutamide bulk offered by Pfizer Inc

    Find a price of Tranexamic Acid bulk offered by Pfizer Inc

    Find a price of Treprostinil Sodium bulk offered by Pfizer Inc

    Find a price of Triazolam bulk offered by Pfizer Inc

    Find a price of Troleandomycin bulk offered by Pfizer Inc

    Find a price of Vancomycin Hydrochloride bulk offered by Pfizer Inc

    Find a price of Vidarabine bulk offered by Pfizer Inc

    Find a price of Viomycin Sulfate bulk offered by Pfizer Inc

    Find a price of Zinc Gluconate API bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN MILAN, ITALY. bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN ARNPRIOR, ONTARIO, CANADA. bulk offered by Pfizer Inc

    Find a price of GEN. INFO APPLICABLE TO THE FINE CHEMICAL OPERATIONS bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN UPPSALA, SWEDEN. bulk offered by Pfizer Inc

    Find a price of ANTIBIOTIC GENERAL INFORMATION bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATION--CI-383 bulk offered by Pfizer Inc

    Find a price of BULK CHEMICALS , METHOD OF PREPARATION bulk offered by Pfizer Inc

    Find a price of QUALITY CONTROL INFORMATION FOR NDA ANTIBIOTIC bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATIONS--CI 400 AND 421 bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATION--CI-446 bulk offered by Pfizer Inc

    Find a price of QUALIFICATIONS OF PARKE, DAVIS & CO. RESEARCH PERSONNEL bulk offered by Pfizer Inc

    Find a price of U-32, 070E (25-HYDROXYCHOLECALCIFEROL) bulk offered by Pfizer Inc

    Find a price of NSC-51173, (U-10955)--5A-ANDROSTAN-3-ONE,2A-FLUORO-17B-HYDROXY bulk offered by Pfizer Inc

    Find a price of MFG, PROCESS & PACK OF INDS IN MORRIS PLAINS, NJ FACIL (710 TABOR RD) bulk offered by Pfizer Inc

    Find a price of IODODOXORUBICIN HCL FOR INJECTION bulk offered by Pfizer Inc

    Find a price of OLEANSOMYCIN AND COCCIDIOSTATS IN POULTRY FEED bulk offered by Pfizer Inc

    Find a price of BIZELESIN (U-77779) DRUG SUBSTANCE bulk offered by Pfizer Inc

    Find a price of WARNER-LAMBERT, CAPS PLANT OPER, BROCKVILLE, ONTARIO, CAN FACILITY bulk offered by Pfizer Inc

    Find a price of FACILITY AND OPERATING PROCEDURES IN STRANGNAS, SWEDEN bulk offered by Pfizer Inc

    Find a price of STYRENE - MALEIC ACID COPOLYMER-TOXIC. DATA, CLIN REPTS & PHYSI CHARAC bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN BRISTOL, TENNESSEE. bulk offered by Pfizer Inc

    Find a price of POLYMYXIN METHANE SULFONATE FOR TREAT. OF DISEASE IN POULTRY (VET) bulk offered by Pfizer Inc

    Find a price of 1-DESOXYEPHEDRINE bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATION--CI-462 bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES OF LARGE VOLUME PARENTERALS IN GLASS BOTTLES IN UPPSALS, SWEDEN. bulk offered by Pfizer Inc

    Find a price of PACKAGING OPERATION bulk offered by Pfizer Inc

    Find a price of VIRAL AND BACTERIAL VACCINES bulk offered by Pfizer Inc

    Find a price of COMBINED ADRENAL HORMONE ANTIBIOTIC THERAPY bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATION--CI 344 bulk offered by Pfizer Inc

    Find a price of PERSONNEL FACILITIES AND OPERATING PROCEDURE bulk offered by Pfizer Inc

    Find a price of CI -404 - ACTINOBOLIN SULFATE bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATION--CI423 bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATION 461 bulk offered by Pfizer Inc

    Find a price of FACILITIES & GENERAL OPERATING PROCEDURES (SANDY, UTAH LOCATION) bulk offered by Pfizer Inc

    Find a price of 16-METHYLDIOLONE ACETATE AND S.D. VII) 9(11)-ANHYDRO-16a METHYLPREDNIS bulk offered by Pfizer Inc

    Find a price of AT THE CHRISTIANSTED, ST. CROIX LOCATION bulk offered by Pfizer Inc

    Find a price of IODODOXORUBICIN HCL BULK DRUG SUBSTANCE bulk offered by Pfizer Inc

    Find a price of MANUFACTURING ,PACKAGING AND CONTROLS PROCEDURES-THIS IS A VET MED DMF bulk offered by Pfizer Inc

    Find a price of FACILITY, PERSONNEL AND OPERATING PROCEDURES IN STOCKHOLM, SWEDEN bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN HILLEROD, DENMARK. bulk offered by Pfizer Inc

    Find a price of FACILITY AND OPERATING PROCEDURES AT THE BRUNNA FACILITY IN KUNGSANGEN, SWEDEN bulk offered by Pfizer Inc

    Find a price of HYDROXY ACID bulk offered by Pfizer Inc

    Find a price of CAPSULE PLANT OPERATION AT THE DETROIT, MICHIGAN FACILITY bulk offered by Pfizer Inc

    Find a price of METHODS, FACILS & CONTRLS bulk offered by Pfizer Inc

    Find a price of FACILITIES, PERSONNEL & EQUIPMENT IN SANDWICH, KENT, ENGLAND bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, OPERATING PROCEDURES AND PERSONNEL IN UPPSALA, SWEDEN. bulk offered by Pfizer Inc

    Find a price of MANUFACTURING FACILITIES IN COLUMBUS, OHIO bulk offered by Pfizer Inc

    Find a price of W 3361, A LIQUID ANTACID FORMULATION ---CHITOSAN ANTACID bulk offered by Pfizer Inc

    Find a price of PELLETHANE MDI BASED URETHANE ELASTOMER bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATION-- CI-395 bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES bulk offered by Pfizer Inc

    Find a price of ARA-CYTIDINE 5 - BENZOATE (U - 32,072E) bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATION--CI 384 bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN GWENT, UNITED KINGDOM. bulk offered by Pfizer Inc

    Find a price of (U-31, 583) 1-B-D-ARABINOFURANOSYLCYTOSINE 5'-PALMITATE bulk offered by Pfizer Inc

    Find a price of CLINICAL INVESTIGATION --CI 442 bulk offered by Pfizer Inc

    Find a price of FACILITIES AND CONTROLS IN WEST SUSSEX, U.K. bulk offered by Pfizer Inc

    Find a price of PERSONNEL, FACILITIES & GENERAL OPERATING PROCEDURES bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE FACILITIES OPERATING PROCEDURES AND PERSONNEL OF THE GS/API PROCESS R&D PLANT IN NERVIANO ITALY bulk offered by Pfizer Inc

    Find a price of MANUFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN PARSIPPANY, NEW JERSEY. bulk offered by Pfizer Inc

    Find a price of METHODS, FACILITIES AND CONTROLS bulk offered by Pfizer Inc

    Find a price of PERSONNEL, FACILS & GEN OPER PROCEDS AT THE LITITZ, PA FACILITY bulk offered by Pfizer Inc

    Find a price of FACILS. & CONTROLS LOCATED IN FJARDO, PUERTO RICO FACILITY bulk offered by Pfizer Inc

    Find a price of 17-DESOXY OXIDO bulk offered by Pfizer Inc

    Find a price of FACILITY AND OPERATING PROCEDURES IN STOCKHOLM, SWEDEN bulk offered by Pfizer Inc

    Find a price of MANFACTURING SITE, FACILITIES, PERSONNEL, AND GENERAL OPERATING PROCEDURES IN JOHANNESHOV, SWEDEN. bulk offered by Pfizer Inc

    Find a price of SOLKETAL(GLYCEROL 1,2 - ISOPROPYLIDENE ETHER) bulk offered by Pfizer Inc

    Find a price of VIRAL AND BACTERIAL VACCINE bulk offered by Pfizer Inc

    Find a price of Abrocitinib bulk offered by Pfizer Inc

    Find a price of Alprostadil bulk offered by Pfizer Inc

    Find a price of Amlodipine Besylate bulk offered by Pfizer Inc

    Find a price of Anidulafungin bulk offered by Pfizer Inc

    Find a price of Axitinib bulk offered by Pfizer Inc

    Find a price of Azithromycin bulk offered by Pfizer Inc

    Find a price of Azithromycin Dihydrate bulk offered by Pfizer Inc

    Find a price of Bosutinib Monohydrate bulk offered by Pfizer Inc

    Find a price of Ceftiofur bulk offered by Pfizer Inc

    Find a price of Celecoxib bulk offered by Pfizer Inc

    Find a price of Conjugated Estrogens bulk offered by Pfizer Inc

    Find a price of Crisaborole bulk offered by Pfizer Inc

    Find a price of Crizotinib bulk offered by Pfizer Inc

    Find a price of Dacomitinib bulk offered by Pfizer Inc

    Find a price of Desvenlafaxine Succinate bulk offered by Pfizer Inc

    Find a price of Dexamethasone bulk offered by Pfizer Inc

    Find a price of Dexamethasone Sodium Phosphate bulk offered by Pfizer Inc

    Find a price of Dinoprost Tromethamine bulk offered by Pfizer Inc

    Find a price of Doxazosin Mesylate bulk offered by Pfizer Inc

    Find a price of Eletriptan Hydrobromide bulk offered by Pfizer Inc

    Find a price of Ertugliflozin bulk offered by Pfizer Inc

    Find a price of Estradiol Benzoate bulk offered by Pfizer Inc

    Find a price of Fesoterodine bulk offered by Pfizer Inc

    Find a price of Fluconazole bulk offered by Pfizer Inc

    Find a price of Hydrocortisone Acetate bulk offered by Pfizer Inc

    Find a price of Latanoprost bulk offered by Pfizer Inc

    Find a price of Linezolid bulk offered by Pfizer Inc

    Find a price of Lorlatinib bulk offered by Pfizer Inc

    Find a price of Maropitant bulk offered by Pfizer Inc

    Find a price of Mavacoxib bulk offered by Pfizer Inc

    Find a price of Melengestrol Acetate bulk offered by Pfizer Inc

    Find a price of Nirmatrelvir bulk offered by Pfizer Inc

    Find a price of Novobiocin Sodium bulk offered by Pfizer Inc

    Find a price of Oclacitinib Maleate bulk offered by Pfizer Inc

    Find a price of Opiranserin Hydrochloride bulk offered by Pfizer Inc

    Find a price of Palbociclib bulk offered by Pfizer Inc

    Find a price of Pegvisomant bulk offered by Pfizer Inc

    Find a price of Phenytoin bulk offered by Pfizer Inc

    Find a price of Prazosin Hydrochloride bulk offered by Pfizer Inc

    Find a price of Pregabalin bulk offered by Pfizer Inc

    Find a price of Progesterone bulk offered by Pfizer Inc

    Find a price of Sertraline Hydrochloride bulk offered by Pfizer Inc

    Find a price of Sildenafil Citrate bulk offered by Pfizer Inc

    Find a price of Spectinomycin bulk offered by Pfizer Inc

    Find a price of Sunitinib bulk offered by Pfizer Inc

    Find a price of Tafamidis bulk offered by Pfizer Inc

    Find a price of Taliglucerase Alfa bulk offered by Pfizer Inc

    Find a price of Testosterone bulk offered by Pfizer Inc

    Find a price of Testosterone Cypionate bulk offered by Pfizer Inc

    Find a price of Testosterone Propionate bulk offered by Pfizer Inc

    Find a price of Testosterone Undecanoate bulk offered by Pfizer Inc

    Find a price of Tigecycline bulk offered by Pfizer Inc

    Find a price of Tofacitinib Citrate bulk offered by Pfizer Inc

    Find a price of Tolterodine Tartrate bulk offered by Pfizer Inc

    Find a price of Trenbolone bulk offered by Pfizer Inc

    Find a price of Tulathromycin bulk offered by Pfizer Inc

    Find a price of Varenicline Tartrate bulk offered by Pfizer Inc

    Find a price of Voriconazole bulk offered by Pfizer Inc

    Find a price of Ziprasidone Hydrochloride bulk offered by Pfizer Inc

    Find a price of Ziprasidone Mesylate bulk offered by Pfizer Inc

    Find a price of Rittlesitinib tosylate bulk offered by Pfizer Inc

    Find a price of DERQUANTEL bulk offered by Pfizer Inc

    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.